← SynDRA

ROVAZOLAC

SynDRA canonical compound SYN0039427 — structure-anchored drug synonym record

All known targets

• NR1H2
• NR1H3

Mechanisms of action (all sources)

• NR1H3 AGONIST
• Liver X receptor agonist
• NR1H2 AGONIST
• LXR agonist

Cross-references

• PubChem CID: 89792952
• ChEMBL: CHEMBL4297218
• DrugBank: DB16320
• TTD: D0CT5O

Synonyms

• ALX-101
• UNII-W51K389XIL
• W51K389XIL
• Rovazolac [INN]
• GTPL9625
• SCHEMBL15242823
• ZUMNJDGBYXHASJ-UHFFFAOYSA-N
• example 36 [WO2013130892]
• HY-109073
• CS-0033536
• A-110
• ethyl 2-[5-[4-(3-methylsulfonylphenyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]acetate
• ethyl 2-(5-(3'-(methylsulfonyl)biphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate
• ethyl 2-(5-(3'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate
• Ethyl 2-(5-(3'-(methylsulfonyl)-(1,1'-biphenyl)-4-yl)-3-(trifluoromethy
• pagibaximabum
• RefChem:858292
• PAGIBAXIMAB [INN]
• Pagibaximab [USAN:INN]
• PAGIBAXIMAB [USAN]
• BSYX-A110
• BSYX-A 110
• (trifluoromethyl)-1H-pyrazol-1-yl}acetate
• orb1706691
• C21H19F3N2O4S
• ethyl {5-[3'-(methanesulfonyl)[1,1'-biphenyl]-4-yl]-3-
• MFCD31657370
• AKOS040742578
• DA-77543
• MS-28220
• G16303
• T16792
• Pagibaximab